Abstract

The Side Effects of Drugs Annuals form a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions . This review of the 2011 publications on adverse reactions to blood, blood components, plasma, and plasma products covers albumin, blood transfusion (erythrocytes and platelets), blood substitutes (hemoglobin-based oxygen carriers), plasma products (C1 esterase inhibitor concentrate and fresh frozen plasma), plasma substitutes (dextrans, etherified starches, and gelatin), globulins (intravenous immunoglobulin, subcutaneous immunoglobulin, and anti-D immunoglobulin), coagulation proteins (factor VIIa, factor VIII, factor IX, prothrombin complex concentrate, and von Willebrand factor/factor VIII concentrates), erythropoietin and derivatives, and stem cells. This includes blood products for which hemovigilance is in force, plasma products that must comply with pharmacovigilance regulations, substitute products, and stem cells. Because blood and plasma products originate from human blood through blood donation, prevention of transmitted infections (by, for example, bacteria, viruses, protozoa, and prions) form the use of blood, blood components, plasma, and plasma-derived medicinal products is of paramount importance. Nowadays, the risk of transmission of the lipid-enveloped viruses, human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) by plasma-derived medicinal products is considered negligible.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.